Please assess the completion status of the following clinical trial:

Trial Title: EdemaWear to Reduce Edema in Hospitalized Patients With CVI:

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* history of CVI (Clinical classification 1-5), with \> 2+ edema of the lower legs,~* \> 2+ peripheral pulses (popliteal, dorsalis pedis \[DP\], and posterior tibial \[PT\]) or audible biphasic / triphasic Doppler signal, if pulses not palpable.~Exclusion Criteria:~* open venous stasis ulcer(s) or other wounds on lower legs~* lymphedema or risk factors for lymphedema~* acute heart failure with active management~* known deep vein thrombosis (DVT) with subtherapeutic anticoagulation~* peripheral arterial disease (PAD) with reduced / absent pulses~* known or suspected inferior vena caval (IVC) compression~* circumference of lower leg \< 45 cm or \> 115 cm (size limits of small and extra-large EdemaWear®)~* severely altered mental status or lacking capacity to consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Edema Wear (Type: EXPERIMENTAL): Edema Wear fuzzy wale compression garment worn on lower extremities continuously for 5 days or until discharge if less than 5 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).